Medical Disorders
Resources
Basic InformationLookupsLatest News
Insurance Often Covers Ivermectin for COVID, Even Though Drug Doesn't WorkCOVID Cases Surge Again in U.S. Nursing HomesCBD and Cannabis Products for Acne, Psoriasis? Buyer Beware, Dermatologists SayCarbon Monoxide Deaths Soar During Power OutagesAHA News: Transplanting Pig Hearts Into Humans Offers Promise – and PerilCOVAX Program Has Now Sent 1 Billion COVID Vaccines to Poorer NationsCOVID Fatigue: Are You Among the 'Vaxxed & Done'?CDC Advises N95s as Best Masks Against CoronavirusYou Don't Have to Be a Smoker to Get Lung CancerSkipping COVID Vaccine in Pregnancy Brings Big Risks to Mothers, BabiesMasks Cut Distance Coronavirus Travels in Half, Study Finds1 in 10 People With COVID Still Infectious After 10 Days: StudyWorried About Omicron? Expert Offers Tips on Going Out SafelySupreme Court Blocks Biden's Vaccine Mandate for Large EmployersCould the 'Mono' Virus Help Trigger Multiple Sclerosis?AHA News: Obesity Harms Brain Health Throughout Life – Yet Scientists Don't Know WhyWhite House May Soon Offer 'High-Quality' Masks to AmericansCOVID Hospitalizations Rising in Kids Too Young for VaccineProgress on Lung Cancer Drives Overall Decline in U.S. Cancer DeathsNearly 600,000 U.S. Kids Had COVID Last WeekWildfires Plus Heat Make Breathing Dangerous in America's WestHow Safe Is a 'Holiday' From Bone-Strengthening Meds?White House to Give Schools 10 Million Free COVID Tests Every MonthBinaxNOW Test Catches COVID Infection in Many People, Study ShowsU.S. May Soon See Sharp Drop in Omicron Cases, Experts SayAs Omicron Rages, How Important Are Case Counts Anymore?Americans Should Avoid Travel to Canada: CDCRed Cross Says U.S. Blood Supply at Dangerously Low LevelPfizer Says Omicron-Specific Vaccine Ready by MarchRain or Shine, Allergies Are Tough. What's the Link to Weather?U.S. Insurers Must Cover 8 COVID At-Home Tests a Month: White HouseU.S. COVID Hospitalizations Pass Last Winter's PeakIn Breakthrough Transplant, Man Receives Genetically Modified Pig HeartExposure to Common Cold Might Help Shield Against COVIDDrug Combo Boosts Outcomes for Advanced MelanomaDo Not Use At-Home COVID Test Swabs in the Throat: FDAEven Symptom-Free, People With Omicron Much More Likely to Spread COVID: StudiesWant to Avoid Glaucoma? Look at What You EatNew Worry: 'Flurona,' When COVID Meets the FluAmid COVID Test Shortages, Price Gouging Is on the RiseNeed an At-Home COVID Test? Here's Help Finding and Using OneKnow Your Thyroid FactsFDA Shortens Time to Booster After Moderna Vaccine to 5 MonthsCOVID Vaccine May Temporarily Add 1 Day to Menstrual Cycle: StudyHospitals Are Rationing COVID Pills, Infusions as Cases RiseBreakthrough COVID Cases Overwhelmingly Mild for Vaccinated People: StudySupreme Court Hears Arguments on Biden's Vaccine Mandate for Big BusinessMore Evidence That State Lotteries Didn't Boost Vaccination RatesWhite House Finalizes Plan to Send Americans Free COVID Rapid TestsModerna CEO Says 4th COVID Dose May Be Needed Next Fall
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Could the 'Mono' Virus Help Trigger Multiple Sclerosis?

HealthDay News
by By Amy Norton HealthDay Reporter
Updated: Jan 14th 2022

new article illustration

FRIDAY, Jan. 14, 2022 (HealthDay News) -- For years, researchers have suspected that the Epstein-Barr virus, best known for causing mononucleois, might also play a role in triggering multiple sclerosis. Now a new study strengthens the case.

The study, of more than 10 million U.S. military personnel, found the risk of developing multiple sclerosis (MS) shot up 32-fold after infection with Epstein-Barr.

Epstein-Barr virus (EBV) is ubiquitous, with about 95% of the population becoming infected at some point. Many people contract it as children, when it usually causes no symptoms. When people become infected as teenagers or young adults, it may cause mononucleosis.

Over the years, a number of studies have hinted that, in a small number of people, EBV may help raise the risk of multiple sclerosis. MS is a neurological disease caused by a misguided immune system attack on the body's own nerve tissue.

People who've had mononucleosis, for example, are at higher risk of developing MS than those who never suffered symptoms from EBV infection. Meanwhile, people with MS can show high levels of antibodies against EBV several years before their symptoms surface. Researchers have also found EBV-infected B-cells in the brains of MS patients.

It all hints that something about the immune response to EBV infection can, in certain people, prompt the development of MS.

But proving the virus is a cause of MS, and not just a bystander, has been challenging. That's partly because nearly everyone is infected with EBV, while MS is relatively rare.

It takes a massive and long-term study to identify people who are initially EBV-negative, then see whether a new EBV infection raises their risk of subsequently developing MS.

The new study, published in the journal Science, did just that.

"This is the strongest evidence we have to date that EBV contributes to MS," said Mark Allegretta, vice president of research for the nonprofit National MS Society.

Allegretta, who was not involved in the study, said the virus is likely "necessary, but not sufficient" to cause MS. That is, it conspires with other factors that make people more vulnerable to developing MS.

At this point, studies have identified some other factors linked to higher MS risk, said study senior author Dr. Alberto Ascherio.

Those include certain genes, as well as smoking, vitamin D deficiency and childhood obesity, said Ascherio, a professor of epidemiology at Harvard Medical School.

None of those factors, however, approach the 32-fold increase in risk tied to EBV infection, Ascherio said.

He called the latest findings "compelling evidence" of the virus's role in causing MS.

In the study, U.S. military personnel were tracked for over 20 years. All had blood samples taken at enlistment, and then every two years.

Ascherio's team found that about 5% were EBV-negative at the time of the first test.

Overall, 955 military personnel were diagnosed with MS while on active duty. That included 35 who'd initially been EBV-negative. All but one of those individuals became infected with EBV before their MS diagnosis -- typically five years prior.

Compared with their counterparts who remained EBV-negative, those newly infected with the virus had a 32-times higher risk of developing MS during the study period.

One question is whether people in the pre-symptomatic stages of MS have a dysfunctional immune system that makes them more prone to viral infections in general.

So Ascherio's team looked at whether MS risk was associated with other viral infections in the military personnel, including cytomegalovirus -- another common virus that remains dormant in the body for life. They found no similar link between those viruses and MS.

Ascherio said it's likely that something about the immune response to EBV, specifically, helps trigger MS. Exactly what remains unclear.

An editorial published with the study echoed the idea that EBV is necessary, but not enough on its own, to cause MS.

Infection is the initial step, but other "fuses must be ignited" to cause MS, wrote Drs. William Robinson and Lawrence Steinman, of Stanford University in California.

They raise the question of whether vaccines against EBV could help prevent MS. Such vaccines are under development: Moderna, maker of one of the messenger RNA COVID vaccines, just started an early trial of an mRNA vaccine against EBV.

Another possibility, Ascherio said, is that antivirals that target EBV-infected cells could be tested for treating MS.

Some newer medications for MS slow the progression of the disease by depleting certain B-cells in the body. Allegretta said it's "reasonable" to speculate that one reason the drugs work is by reducing EBV-infected B cells.

More information

The National MS Society has more on the causes of MS.


SOURCES: Alberto Ascherio, M.D., Dr.Ph., professor, medicine, Harvard Medical School, professor, epidemiology and nutrition, Harvard TH Chan School of Public Health, Boston; Mark Allegretta, Ph.D., vice-president of research, National MS Society, New York City; Jan. 13, 2022 Science, online




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net